Observational analysis shows KDIGO-defined kidney dysfunction predicts CKD progression and mortality in adults with sickle cell disease, suggesting significant clinical implications.
Approximately 15% of deaths in adults with sickle cell disease (SCD) are attributed to kidney failure. Although urine albumin-to-creatinine ratio (UACR) is recommended to screen for kidney damage, its utility to predict long-term complications in SCD remains unclear. We investigated whether "Kidney Disease: Improving Global Outcomes (KDIGO)" algorithms used to assess kidney disease in the general population predicted chronic kidney disease (CKD) progression and mortality in a longitudinal cohort of 379 SCD adults from two academic institutions. KIDGO criteria include UACR detected in two consecutive measurements ≥3 months apart and a heat map integrating UACR with estimated glomerular filtration rate. KDIGO-defined CKD was present in 39.8% of individuals in our SCD cohort. Over a median follow up of 3.3 years, incremental KDIGO-defined UACR category independently predicted a 2-fold greater risk of CKD progression and 1.8-fold greater risk of mortality (P≤0.05). KDIGO-defined CKD heat map strengthened the ability to predict CKD progression and mortality risk (P≤0.0087). Our data provides clinical support for the screening utility of UACR based on repeated abnormal values ≥3 months apart. The KDIGO-heat map further refines risk of long-term outcomes in adults with SCD and should be applied to guide future studies for monitoring and intervention strategies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: